NVAX logo

Novavax (NVAX) Cash From Financing

Annual CFF

$4.47 M
-$320.52 M-98.63%

December 31, 2023


Summary


Performance

NVAX Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVAXcash flowmetrics:

Quarterly CFF

-$97.00 K
-$258.31 M-100.04%

September 30, 2024


Summary


Performance

NVAX Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVAXcash flowmetrics:

TTM CFF

$364.39 M
-$197.22 M-35.12%

September 30, 2024


Summary


Performance

NVAX TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVAXcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

NVAX Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-98.6%-100.0%+281.5%
3 y3 years-99.5%+99.8%-21.1%
5 y5 years-95.7%-100.0%+59.7%

NVAX Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-99.0%at low-100.0%+100.0%-35.1%+292.5%
5 y5-year-99.5%at low-100.0%+100.0%-73.5%+292.5%
alltimeall time-99.5%+720.3%-100.0%+100.0%-73.5%+292.5%

Novavax Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$97.00 K(-100.0%)
$364.39 M(-35.1%)
Jun 2024
-
$258.22 M(+4287.0%)
$561.61 M(+54.0%)
Mar 2024
-
$5.89 M(-94.1%)
$364.73 M(+8066.8%)
Dec 2023
$4.47 M(-98.6%)
$100.39 M(-49.1%)
$4.47 M(-95.3%)
Sep 2023
-
$197.12 M(+221.4%)
$95.52 M(-172.0%)
Jun 2023
-
$61.34 M(-117.3%)
-$132.58 M(-29.9%)
Mar 2023
-
-$354.38 M(-285.1%)
-$189.26 M(-158.2%)
Dec 2022
$324.99 M(-29.6%)
$191.44 M(-718.0%)
$324.99 M(+346.2%)
Sep 2022
-
-$30.98 M(-764.9%)
$72.84 M(-17.3%)
Jun 2022
-
$4.66 M(-97.1%)
$88.09 M(+97.6%)
Mar 2022
-
$159.87 M(-363.3%)
$44.59 M(-90.3%)
Dec 2021
$461.71 M(-53.1%)
-$60.71 M(+286.2%)
$461.71 M(-50.2%)
Sep 2021
-
-$15.72 M(-59.5%)
$927.03 M(+0.7%)
Jun 2021
-
-$38.84 M(-106.7%)
$920.37 M(-33.1%)
Mar 2021
-
$576.99 M(+42.6%)
$1.38 B(+39.7%)
Dec 2020
$984.76 M(+900.9%)
$404.61 M(-1907.3%)
$984.76 M(+61.4%)
Sep 2020
-
-$22.39 M(-105.4%)
$610.32 M(-5.3%)
Jun 2020
-
$416.62 M(+124.1%)
$644.74 M(+182.6%)
Mar 2020
-
$185.92 M(+516.2%)
$228.13 M(+131.9%)
Dec 2019
$98.38 M(-4.3%)
$30.17 M(+150.8%)
$98.38 M(+36.5%)
Sep 2019
-
$12.03 M(>+9900.0%)
$72.07 M(+18.0%)
Jun 2019
-
$3000.00(-100.0%)
$61.06 M(-46.9%)
Mar 2019
-
$56.18 M(+1356.6%)
$115.06 M(+11.9%)
Dec 2018
$102.81 M(+59.3%)
$3.86 M(+278.1%)
$102.81 M(-11.7%)
Sep 2018
-
$1.02 M(-98.1%)
$116.36 M(-16.3%)
Jun 2018
-
$54.00 M(+22.9%)
$138.97 M(+49.3%)
Mar 2018
-
$43.92 M(+152.2%)
$93.10 M(+44.3%)
Dec 2017
$64.54 M(-76.9%)
$17.41 M(-26.3%)
$64.54 M(+34.8%)
Sep 2017
-
$23.63 M(+190.6%)
$47.89 M(+93.6%)
Jun 2017
-
$8.13 M(-47.1%)
$24.74 M(+46.7%)
Mar 2017
-
$15.36 M(+1908.4%)
$16.86 M(-94.0%)
Dec 2016
$279.85 M(+34.4%)
$765.00 K(+59.4%)
$279.85 M(+0.2%)
Sep 2016
-
$480.00 K(+89.7%)
$279.29 M(-2.8%)
Jun 2016
-
$253.00 K(-99.9%)
$287.33 M(-1.3%)
Mar 2016
-
$278.35 M(>+9900.0%)
$291.14 M(+39.8%)
Dec 2015
$208.28 M(+89.8%)
$201.00 K(-97.6%)
$208.28 M(-0.0%)
Sep 2015
-
$8.52 M(+109.7%)
$208.35 M(+4.0%)
Jun 2015
-
$4.06 M(-97.9%)
$200.41 M(-34.1%)
Mar 2015
-
$195.50 M(>+9900.0%)
$304.04 M(+177.1%)
Dec 2014
$109.72 M(-16.3%)
$268.00 K(-53.9%)
$109.72 M(+0.2%)
Sep 2014
-
$581.00 K(-99.5%)
$109.54 M(-52.0%)
Jun 2014
-
$107.70 M(+9105.0%)
$228.33 M(+82.6%)
Mar 2014
-
$1.17 M(+1171.7%)
$125.02 M(-4.6%)
Dec 2013
$131.03 M(+143.6%)
$92.00 K(-99.9%)
$131.03 M(-17.1%)
Sep 2013
-
$119.37 M(+2618.5%)
$157.97 M(+243.5%)
Jun 2013
-
$4.39 M(-38.9%)
$45.98 M(-14.4%)
Mar 2013
-
$7.18 M(-73.4%)
$53.71 M(-0.1%)
Dec 2012
$53.79 M(+383.3%)
$27.03 M(+266.0%)
$53.79 M(+88.0%)
Sep 2012
-
$7.38 M(-39.1%)
$28.61 M(+29.2%)
Jun 2012
-
$12.12 M(+66.9%)
$22.15 M(+30.0%)
Mar 2012
-
$7.26 M(+292.2%)
$17.04 M(+53.1%)
Dec 2011
$11.13 M(-52.5%)
$1.85 M(+100.5%)
$11.13 M(+8.7%)
Sep 2011
-
$923.00 K(-86.8%)
$10.24 M(-63.9%)
Jun 2011
-
$7.00 M(+417.5%)
$28.36 M(+14.6%)
Mar 2011
-
$1.35 M(+41.2%)
$24.74 M(+5.6%)
Dec 2010
$23.43 M
$958.00 K(-95.0%)
$23.43 M(-46.1%)
Sep 2010
-
$19.04 M(+461.9%)
$43.50 M(+30.3%)
DateAnnualQuarterlyTTM
Jun 2010
-
$3.39 M(+8818.4%)
$33.38 M(-22.3%)
Mar 2010
-
$38.00 K(-99.8%)
$42.98 M(+1.6%)
Dec 2009
$42.29 M(+148.9%)
$21.03 M(+135.7%)
$42.29 M(+97.3%)
Sep 2009
-
$8.92 M(-31.3%)
$21.43 M(-28.6%)
Jun 2009
-
$12.99 M(-2098.6%)
$30.02 M(+83.2%)
Mar 2009
-
-$650.00 K(-480.1%)
$16.39 M(-3.6%)
Dec 2008
$16.99 M(-2460.0%)
$171.00 K(-99.0%)
$16.99 M(+4.5%)
Sep 2008
-
$17.51 M(-2806.6%)
$16.26 M(-1468.9%)
Jun 2008
-
-$647.00 K(+1370.5%)
-$1.19 M(-12.2%)
Mar 2008
-
-$44.00 K(-92.1%)
-$1.35 M(+87.9%)
Dec 2007
-$720.00 K(-101.3%)
-$558.00 K(-1014.8%)
-$720.00 K(-248.1%)
Sep 2007
-
$61.00 K(-107.5%)
$486.00 K(+224.0%)
Jun 2007
-
-$812.00 K(-237.9%)
$150.00 K(-82.9%)
Mar 2007
-
$589.00 K(-9.1%)
$879.00 K(-98.5%)
Dec 2006
$56.89 M(+184.6%)
$648.00 K(-335.6%)
$56.89 M(-22.6%)
Sep 2006
-
-$275.00 K(+231.3%)
$73.53 M(-4.7%)
Jun 2006
-
-$83.00 K(-100.1%)
$77.12 M(+0.3%)
Mar 2006
-
$56.60 M(+227.4%)
$76.90 M(+284.7%)
Dec 2005
$19.99 M(-8.9%)
$17.29 M(+421.7%)
$19.99 M(+655.1%)
Sep 2005
-
$3.31 M(-1172.5%)
$2.65 M(-87.8%)
Jun 2005
-
-$309.00 K(+0.7%)
$21.70 M(-1.0%)
Mar 2005
-
-$307.00 K(+502.0%)
$21.91 M(-0.2%)
Dec 2004
$21.95 M(-50.2%)
-$51.00 K(-100.2%)
$21.95 M(-54.1%)
Sep 2004
-
$22.36 M(<-9900.0%)
$47.81 M(+87.6%)
Jun 2004
-
-$94.00 K(-65.2%)
$25.48 M(-5.8%)
Mar 2004
-
-$270.00 K(-101.0%)
$27.04 M(-38.7%)
Dec 2003
$44.09 M(+222.2%)
$25.81 M(>+9900.0%)
$44.09 M(+133.5%)
Sep 2003
-
$41.00 K(-97.2%)
$18.88 M(+0.3%)
Jun 2003
-
$1.47 M(-91.3%)
$18.83 M(-36.4%)
Mar 2003
-
$16.78 M(+2724.9%)
$29.59 M(+116.2%)
Dec 2002
$13.69 M(-11.2%)
$594.00 K(-7525.0%)
$13.69 M(-0.7%)
Sep 2002
-
-$8000.00(-100.1%)
$13.78 M(-49.0%)
Jun 2002
-
$12.22 M(+1292.1%)
$27.02 M(+73.1%)
Mar 2002
-
$878.00 K(+27.4%)
$15.61 M(+1.3%)
Dec 2001
$15.41 M(-59.0%)
$689.00 K(-94.8%)
$15.41 M(-56.7%)
Sep 2001
-
$13.23 M(+1531.4%)
$35.58 M(+54.3%)
Jun 2001
-
$811.00 K(+18.7%)
$23.05 M(+3.4%)
Mar 2001
-
$683.00 K(-96.7%)
$22.30 M(-40.6%)
Dec 2000
$37.56 M(+794.3%)
$20.85 M(+2836.6%)
$37.56 M(+123.4%)
Sep 2000
-
$710.00 K(+1167.9%)
$16.81 M(+3.8%)
Jun 2000
-
$56.00 K(-99.6%)
$16.20 M(-19.6%)
Mar 2000
-
$15.94 M(>+9900.0%)
$20.14 M(+379.6%)
Dec 1999
$4.20 M(+250.0%)
$100.00 K(0.0%)
$4.20 M(-481.8%)
Sep 1999
-
$100.00 K(-97.5%)
-$1.10 M(0.0%)
Jun 1999
-
$4.00 M(>+9900.0%)
-$1.10 M(-77.6%)
Mar 1999
-
$0.00(-100.0%)
-$4.90 M(-508.3%)
Dec 1998
$1.20 M(-77.8%)
-$5.20 M(-5300.0%)
$1.20 M(-82.1%)
Sep 1998
-
$100.00 K(-50.0%)
$6.70 M(+1.5%)
Jun 1998
-
$200.00 K(-96.7%)
$6.60 M(+1.5%)
Mar 1998
-
$6.10 M(+1933.3%)
$6.50 M(+20.4%)
Dec 1997
$5.40 M(+170.0%)
$300.00 K(>+9900.0%)
$5.40 M(-21.7%)
Sep 1997
-
$0.00(-100.0%)
$6.90 M(0.0%)
Jun 1997
-
$100.00 K(-98.0%)
$6.90 M(0.0%)
Mar 1997
-
$5.00 M(+177.8%)
$6.90 M(+245.0%)
Dec 1996
$2.00 M
$1.80 M(>+9900.0%)
$2.00 M(+900.0%)
Sep 1996
-
$0.00(-100.0%)
$200.00 K(0.0%)
Jun 1996
-
$100.00 K(0.0%)
$200.00 K(+100.0%)
Mar 1996
-
$100.00 K
$100.00 K

FAQ

  • What is Novavax annual cash flow from financing activities?
  • What is the all time high annual CFF for Novavax?
  • What is Novavax annual CFF year-on-year change?
  • What is Novavax quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Novavax?
  • What is Novavax quarterly CFF year-on-year change?
  • What is Novavax TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Novavax?
  • What is Novavax TTM CFF year-on-year change?

What is Novavax annual cash flow from financing activities?

The current annual CFF of NVAX is $4.47 M

What is the all time high annual CFF for Novavax?

Novavax all-time high annual cash flow from financing activities is $984.76 M

What is Novavax annual CFF year-on-year change?

Over the past year, NVAX annual cash flow from financing activities has changed by -$320.52 M (-98.63%)

What is Novavax quarterly cash flow from financing activities?

The current quarterly CFF of NVAX is -$97.00 K

What is the all time high quarterly CFF for Novavax?

Novavax all-time high quarterly cash flow from financing activities is $576.99 M

What is Novavax quarterly CFF year-on-year change?

Over the past year, NVAX quarterly cash flow from financing activities has changed by -$197.22 M (-100.05%)

What is Novavax TTM cash flow from financing activities?

The current TTM CFF of NVAX is $364.39 M

What is the all time high TTM CFF for Novavax?

Novavax all-time high TTM cash flow from financing activities is $1.38 B

What is Novavax TTM CFF year-on-year change?

Over the past year, NVAX TTM cash flow from financing activities has changed by +$268.88 M (+281.50%)